Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
07/2007
07/05/2007US20070155719 Platelet ADP receptor inhibitors
07/05/2007US20070155717 Amidines and derivatives thereof and pharmaceutical compositions containing them
07/05/2007US20070155701 Keto cannabinoids with therapeutic indications
07/05/2007US20070155670 Pyrrolidine Melanocortin-Specific Compounds
07/05/2007US20070154980 Fluorescent dyes
07/05/2007US20070154428 Thiazole derivative
07/05/2007US20070151046 Neutral and cationic naphthalene and colorants for keratin fibers containing these compounds
07/05/2007DE102005062991A1 Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln Substituted thiazoles and their use for the preparation of medicaments
07/05/2007DE102005062990A1 Substituierte Thiazole und ihre Verwendung zur Herstellung von Arzneimitteln Substituted thiazoles and their use for the preparation of medicaments
07/05/2007DE102005062986A1 Substituierte Propiolsäureamide und ihre Verwendung zur Herstellung von Arzneimitteln Substituted Propiolsäureamide and their use for the preparation of medicaments
07/05/2007DE102005054700A1 Neue duale Peptidase-Inhibitoren als Prodrugs zur Therapie von entzündlichen und anderen Erkrankungen New dual peptidase inhibitors as prodrugs for the treatment of inflammatory and other diseases
07/05/2007CA2642130A1 Selective benzylamine derivatives and their utility as cholesterol ester-transfer protein inhibitors
07/05/2007CA2634999A1 Muscarinic agonists and methods of use thereof
07/05/2007CA2634794A1 Macrocyclic factor viia inhibitors useful as anticoagulants
07/05/2007CA2634442A1 Calcium channel antagonists
07/05/2007CA2634198A1 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
07/05/2007CA2633653A1 Heterocyclic derivatives as modulators of ion channels
07/05/2007CA2633584A1 Glucokinase activators
07/05/2007CA2633042A1 Niacin receptor agonists, compositions containing such compounds and methods of treatment
07/05/2007CA2631777A1 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
07/04/2007EP1803720A1 Heterocyclindazole and -azaindazole compounds as 5-hydroxytryptamine-6 ligands
07/04/2007EP1803709A1 Proton pump inhibitors
07/04/2007EP1802615A1 Phosphodiesterase 4 inhibitors
07/04/2007EP1802614A1 Quinazolinylmethylenethiazolinones as cdk1 inhibitors
07/04/2007EP1802608A1 Quinazoline derivatives for use against cancer
07/04/2007EP1802602A1 Substituted dipiperdine ccr2 antagonists
07/04/2007EP1802591A1 Quinazoline derivatives
07/04/2007EP1802585A1 4-substituted 4,6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms
07/04/2007EP1802575A1 Polymorph of n,n-diethyl-4-(3-fluorophenyl-piperidin-4-ylidene-methyl)-benzamide hydrochloride salt
07/04/2007EP1802572A1 Indol derivatives as inhibitors of soluble adenylyl cyclase
07/04/2007EP1644343B1 5-substituted quinazolinone derivatives
07/04/2007EP1484971B1 Use of 4-aminopyrimidines for the antimicrobial treatment of surfaces
07/04/2007EP1286964B1 Heterocyclic inhibitors of glycogen synthase kinase gsk-3
07/04/2007CN1993359A Heterocycle -substituted cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors
07/04/2007CN1993358A Thiazole derivatives as chemokine receptor antagonists
07/04/2007CN1993349A Quinazoline derivatives as ERBB receptor tyrosine kinases
07/04/2007CN1993331A N- (1- (1-benzyl -4-phenyl-1h-imidazol-2-yl) -2,2-dymethylpropyl) benzamide derivatives and related compounds as kinesin spindle protein (ksp) inhibitors for the treatment of cancer
07/04/2007CN1993329A Quinoline derivatives as neurokinin receptor antagonists
07/04/2007CN1993325A Piperidine derivatives as histamine h3 receptor ligands
07/04/2007CN1993319A Benzyloxy derivatives as MAOB inhibitors
07/04/2007CN1990486A N-glycyl-pyrrolidine-2-nitrile and its use as DDP-IV enzyme inhibitor
07/04/2007CN1990474A 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
07/04/2007CN1990469A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1990468A Pyrrolidines as dipeptidyl peptidase inhibitors
07/04/2007CN1989969A Cyclic protein tyrosine kinase inhibitors
07/04/2007CN1324022C Inhibitors of tyrosine kinases
07/04/2007CN1324012C TNF-alpha prodn. inhibitors
07/03/2007US7238813 Antiproliferative agents; angiogenesis factor; wound healing agents; antiischemic agents; anticholesterol agents; antitumor, anticancer agents
07/03/2007US7238811 Chemical compounds
07/03/2007US7238809 Process for the preparation of inhibitors of macrophage migration inhibitory factor
07/03/2007US7238724 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
07/03/2007US7238716 Alkanoic acid derivatives process for their production and use thereof
07/03/2007US7238714 Analgesics; antiinflammatory agents; antiarthritic agents
07/03/2007US7238713 Muscarinic agonists
07/03/2007US7238709 Respiratory system disorders; bronchitis; irritable bowel disorders; incontinence
07/03/2007US7238697 Insecticides for crops
07/03/2007US7238692 Stent or a drug delivery or elution device with a disposed traiazine compound such as 6-(3-Chloro-4-methoxy-phenoxy)-N-cycloheptyl-N'-methyl-N'-(1-methyl-piperidin-4-yl)-[1,3,5]triazine-2,4-diamine for inhibiting smooth muscle proliferation; restenosis and atherosclerosis
07/03/2007US7238691 Piperidine derivatives and their use as modulators of chemokine (especially CCR3) activity
07/03/2007US7238689 Crop and weed selectivity
07/03/2007US7238688 For therapy of allergy, allergy-induced airway responses, congestion, hypotension, cardiovascular disease, hypotension, diseases of the GI tract, hyper and hypo motility and acidic secretion of the gastrointestinal tract, obesity, sleep
07/03/2007US7238684 Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them
07/03/2007CA2273959C Helium-neon excitable reticulocyte dyes derivable from halolepidines
07/03/2007CA2252465C Urea derivatives as inhibitors of impdh enzyme
07/03/2007CA2168021C Vasoconstrictive dihydrobenzopyran derivatives
06/2007
06/28/2007WO2007073296A1 Heterocyclic gaba-b modulators
06/28/2007WO2007072782A1 Carboxylic acid derivative or salt thereof
06/28/2007WO2007072164A2 Estrogen modulators
06/28/2007WO2007071952A1 Piperazine compounds useful as antagonists of c-c chemokines (ccr2b and ccr5) for the treatment of inflammatory diseases
06/28/2007WO2007071585A1 Pestcidal compositions
06/28/2007WO2007071455A1 Sulfoximine-substituted pyrimidines , their preparation and use as drugs
06/28/2007WO2007071358A1 Nicotinic acid derivatives as modulators of metabotropic glutamate receptors
06/28/2007WO2007053499A3 Compounds useful as antagonists of ccr2
06/28/2007WO2007044724A3 Aminopyrimidine, aminopyridine and aniline derivatives inhibitors of pim-i and/or pim-3
06/28/2007WO2007044085A3 Heteroaryl compounds and their uses as therapeutic agents
06/28/2007WO2007026920A3 Amide derivatives as rock inhibitors
06/28/2007WO2006123088A3 4- (thiazol-2-ylthioalkyl) -pyrazoles and their use as herbicides
06/28/2007US20070149605 Substituted pyrrole derivatives as hmg-coa reductase inhibitors
06/28/2007US20070149579 e.g. 4-bromo-N-{[4-(4-fluorophenyl)-2-oxo-2H-chromen-7-yl]methyl}-N-{5-[1-hydroxy-1-(trifluoromethyl)propyl]-1,3,4-oxadiazol-2-yl}benzamide;leukotriene biosynthesis and 5-lipoxygenase (5-LO); inhibitor; antiatherosclerotic, antiasthmatic, antiallergic, antiinflammatory and cytoprotective agents
06/28/2007US20070149574 N-(3,5-Dimethylphenyl)-2-[2-(4-methylpiperazin-1-yl)pyridin-4-ylmethylthio]pyridine-3-carboxamide; 2-(2-Cyclopropylaminopyridin-4-ylmethylthio)-N-(3,5-dimethylphenyl)pyridine-3-carboxamide; cancer, rheumatoid arthritis, age-related macular degeneration, diabetic retinopathy, retinopathy of prematurity
06/28/2007US20070149568 N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
06/28/2007US20070149566 e.g. 4-({(E)-4-[(2-carboxy-6-fluoro-4-quinolinyl)oxy]-2-butenyl}oxy)-6-fluoroquinoline-2-carboxylic acid; antidiabetic, hypoglycemic agent; type II diabetes, dyslipidaemia, obesity, arterial hypertension, atherosclerosis, microangiopathy, macroangiopathy, retinopathy, neuropathy or hyperglycaemia
06/28/2007US20070149565 Nelfinavir conjugates and antibodies useful in immunoassay
06/28/2007US20070149549 Prenylation Inhibitors and Methods of Their Synthesis and Use
06/28/2007US20070149547 Bipyridyl amides as modulators of metabotropic glutamate receptor-5
06/28/2007US20070149546 4-Anilino-quinazoline derivatives as antiproliferative agents
06/28/2007US20070149536 2-[4-Bromomethyl)phenyl-3-phenylquinoxaline 1-2; selectively inhibits one or two of the serine/threonine protein kinase isoforms; antiproliferative
06/28/2007US20070149533 Bicyclic compounds with kinase inhibitory activity
06/28/2007US20070149531 Antiviral agents
06/28/2007US20070149530 Antiviral agents
06/28/2007US20070149523 Thiazole Analogues and Uses Thereof
06/28/2007US20070149514 Indole-phenylsulfonamide derivatives used as ppar-delta activating compounds
06/28/2007US20070149513 Vanilloid receptor ligands and their use in treatments
06/28/2007US20070149512 N-Sulfamoyl-piperidineamides for the treatment or inhibition of obesity and related conditions
06/28/2007US20070149511 Substituted oxazolobenzoisothiazole dioxide derivatives method for production and use thereof
06/28/2007US20070149510 Quinazolinone and benzoxazinone derivatives and uses thereof
06/28/2007US20070149503 Anti-migraine spirocycles
06/28/2007US20070149502 Spirocyclic anti-migraine compounds
06/28/2007US20070148708 Protease inhibitor conjugates and antibodies useful in immunoassay
06/28/2007DE102006047988A1 Salz einer Carbonsäure, welche einen N-substituierten Succinimidthiorest enthält, und nicht vulkanisierte Kautschukzusammensetzung, welche dieses enthält Salt of a carboxylic acid containing an N-substituted Succinimidthiorest, and non-vulcanized rubber composition which contains this
06/28/2007CA2634636A1 3-aminocyclopentanecarboxamides as modulators of chemokine receptors